138 related articles for article (PubMed ID: 1905084)
1. A highly purified factor VIII:c concentrate prepared from cryoprecipitate by ion-exchange chromatography.
Burnouf T; Burnouf-Radosevich M; Huart JJ; Goudemand M
Vox Sang; 1991; 60(1):8-15. PubMed ID: 1905084
[TBL] [Abstract][Full Text] [Related]
2. Direct capture of plasma factor VIII:C by ion exchange chromatography.
Teh LC; Froger M
Vox Sang; 1994; 67(1):8-13. PubMed ID: 7975461
[TBL] [Abstract][Full Text] [Related]
3. Separation of antihemophilic factor VII from human plasma by column chromatography.
Baikar VM; Kamath MV; Vishwanathan C; Varadkar AM; Bharmal SE
Indian J Clin Biochem; 2003 Jan; 18(1):80-6. PubMed ID: 23105376
[TBL] [Abstract][Full Text] [Related]
4. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
Burnouf-Radosevich M; Burnouf T
Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
[TBL] [Abstract][Full Text] [Related]
5. Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography.
Josic D; Schwinn H; Stadler M; Strancar A
J Chromatogr B Biomed Appl; 1994 Dec; 662(2):181-90. PubMed ID: 7719474
[TBL] [Abstract][Full Text] [Related]
6. Preparation of intermediate-purity factor VIII concentrate by direct gel filtration of cryoprecipitate.
Teh LC
Vox Sang; 1993; 65(4):251-7. PubMed ID: 8310677
[TBL] [Abstract][Full Text] [Related]
7. Influence of heat treatment on FVIII:C recovery from freeze dried cryoprecipitate.
Benny AG; Ockelford PA; Johns AS; Scott RH; Woodfield DG; Berry EW
J Clin Pathol; 1988 Sep; 41(9):945-7. PubMed ID: 3142936
[TBL] [Abstract][Full Text] [Related]
8. Characterization of F VIII concentrates produced by two methods incorporating double virus inactivation.
Branović K; Gebauer B; Trescec A; Benko B
Appl Biochem Biotechnol; 1998 Feb; 69(2):99-111. PubMed ID: 9513991
[TBL] [Abstract][Full Text] [Related]
9. Purification of factor VIII/von Willebrand factor from human plasma on immobilized lentil lectin.
Zhou FL; Burnouf-Radosevich M; Burnouf T
Protein Expr Purif; 1994 Apr; 5(2):138-43. PubMed ID: 8054845
[TBL] [Abstract][Full Text] [Related]
10. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.
Foster PR; Griffin BD; Bienek C; McIntosh RV; MacGregor IR; Somerville RA; Steele PJ; Reichl HE
Vox Sang; 2004 Feb; 86(2):92-9. PubMed ID: 15023177
[TBL] [Abstract][Full Text] [Related]
11. [Development and characterization of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
Ristol P; Gensana M; Fernández J; Massot M; Bhattacharya P; Jorquera JI
Sangre (Barc); 1996 Apr; 41(2):125-30. PubMed ID: 9045352
[TBL] [Abstract][Full Text] [Related]
12. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
13. Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.
Schwinn H; Smith A; Wolter D
Arzneimittelforschung; 1989 Oct; 39(10):1302-5. PubMed ID: 2514695
[TBL] [Abstract][Full Text] [Related]
14. Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography.
Mori F; Nardini I; Rossi P; Nardini C; Farina C
Vox Sang; 2008 Nov; 95(4):298-307. PubMed ID: 19138259
[TBL] [Abstract][Full Text] [Related]
15. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
[TBL] [Abstract][Full Text] [Related]
16. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
[TBL] [Abstract][Full Text] [Related]
17. Heparin small pool high yield purified factor VIII: in vivo recovery and half-life of routinely produced freeze-dried concentrate.
Smit Sibinga CT; Daenen SM; van Imhoff GW; Maas A; Das PC
Thromb Haemost; 1984 Feb; 51(1):12-5. PubMed ID: 6426077
[TBL] [Abstract][Full Text] [Related]
18. Development and small-scale production of a severely heated factor VIII concentrate.
Knevelman A; de Wit HJ; Potstra P; vd Does JA
Vox Sang; 1994; 66(2):89-95. PubMed ID: 8184598
[TBL] [Abstract][Full Text] [Related]
19. Purification of coagulation factor VIII using chromatographic methods. Direct chromatography of plasma in anion exchange resins.
Cheng E; Jinzenji D; Lorthiois AP; de Carvalho RR; Tanaka-Azevedo AM; Raw I; Martins EA
Biotechnol Lett; 2010 Sep; 32(9):1207-14. PubMed ID: 20431912
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hemophilia A with a highly purified factor VIII concentrate prepared by anti-FVIIIc immunoaffinity chromatography.
Addiego JE; Gomperts E; Liu SL; Bailey P; Courter SG; Lee ML; Neslund GG; Kingdon HS; Griffith MJ
Thromb Haemost; 1992 Jan; 67(1):19-27. PubMed ID: 1615478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]